Prof. Marks: How to commercialize research and development? Insights from Biotech and healthcare

Tuesday, April 3, 2018, 10:30 AM – 1:00 PM UTC

For our 15th Startup Grind Chengdu we will invite Robert Marks, a professor, serial entrepreneur and biosensor expert. Prof. Robert Marks has dedicated his career to research and development of novel biosensor technologies in areas ranging from medical diagnostics, water safety, environmental monitoring, basic research and more.

In-person event

About this event

The fireside chat will discuss topics like:

1. Understanding of biotech industry, industry trends, application of biotech into our daily lives.

2. What are the differences of technology environment among Israel, Singapore, China and the US? 

3. How to commercialize research and development? 

4. How to deal globally with governments, universities and business relations? 


Prof. Dr. Robert S. Marks is a renowned expert and key opinion leader in the field of biosensors. He is a Full Professor at the Ben-Gurion University of the Negev, Israel, at the Department of Biotechnology Engineering. He is presently a Visiting Scientist at the DxD hub at Astar in Singapore.

Robert has previously co-founded Biosensing Technologies Ltd, Biopixel Ltd and Polyrizon Ltd as well as P@bbles whose mission is to introduce new Israeli ventures into Asia.

He is the Editor-in-Chief of a 2007 2-volume Wiley Handbook in Biosensors and Biochips and a 2014 Viral Diagnostics book for virus detection among other books. He also author of 150+ papers (H-index 27) and has several issued patents as well as a dozen filed.

His startups:

Biosensorix and Eclipse DX aim to provide accurate and convenient diagnostic solutions for rural and urban doctors to save life and save medical costs.

It has developed an point-of-care diagnostic tool that is cheap and easy to use. It can not only be used repeatedly, but also provide quantitative and accurate diagnostic results. In 2016, the global point-of-care diagnostics market was valued at about 19.3 billion US dollars, and Biosensorix aims to account for 8.7 billion of the market. Compared with competitors, their products are affordable, portable and easy to use and can provide quantitative detection. 

Check out what happened


  • Prof. Robert Marks





Tuesday, April 3, 2018
10:30 AM – 1:00 PM UTC


10:30 AMRegistration
11:00 AMIntro & Startup Rallye
11:30 AMFireside Chat
12:15 PMQ&A
12:30 PMNetworking


  • Christoph Hering

    Startup Grind Chengdu

    Chapter Director

  • Lillian Li

    Marketing Manager

  • Xuemei Zhong

    Speaker and Venue Manager

  • Alice Yu

    Sponsorship Manager